ArticleCancer management and research2025
Rhabdomyolysis as a Predominant Multisystem Serious Immune-Related Adverse Event Induced by Sintilimab: A Case Report and Literature Review.
Qingyuan Duan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.